1. Home
  2. VIGL vs EDAP Comparison

VIGL vs EDAP Comparison

Compare VIGL & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • EDAP
  • Stock Information
  • Founded
  • VIGL 2020
  • EDAP 1979
  • Country
  • VIGL United States
  • EDAP France
  • Employees
  • VIGL N/A
  • EDAP N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VIGL Health Care
  • EDAP Health Care
  • Exchange
  • VIGL Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • VIGL 134.9M
  • EDAP 53.8M
  • IPO Year
  • VIGL 2022
  • EDAP 1997
  • Fundamental
  • Price
  • VIGL $8.05
  • EDAP $1.51
  • Analyst Decision
  • VIGL Buy
  • EDAP Buy
  • Analyst Count
  • VIGL 7
  • EDAP 3
  • Target Price
  • VIGL $8.00
  • EDAP $8.50
  • AVG Volume (30 Days)
  • VIGL 1.1M
  • EDAP 36.9K
  • Earning Date
  • VIGL 08-12-2025
  • EDAP 08-27-2025
  • Dividend Yield
  • VIGL N/A
  • EDAP N/A
  • EPS Growth
  • VIGL N/A
  • EDAP N/A
  • EPS
  • VIGL N/A
  • EDAP N/A
  • Revenue
  • VIGL N/A
  • EDAP $67,840,467.00
  • Revenue This Year
  • VIGL N/A
  • EDAP N/A
  • Revenue Next Year
  • VIGL N/A
  • EDAP N/A
  • P/E Ratio
  • VIGL N/A
  • EDAP N/A
  • Revenue Growth
  • VIGL N/A
  • EDAP 3.69
  • 52 Week Low
  • VIGL $1.31
  • EDAP $1.26
  • 52 Week High
  • VIGL $8.06
  • EDAP $5.27
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 88.18
  • EDAP 34.23
  • Support Level
  • VIGL $7.86
  • EDAP $1.51
  • Resistance Level
  • VIGL $8.05
  • EDAP $1.63
  • Average True Range (ATR)
  • VIGL 0.02
  • EDAP 0.10
  • MACD
  • VIGL -0.15
  • EDAP -0.01
  • Stochastic Oscillator
  • VIGL 73.15
  • EDAP 3.33

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: